SCHEMBL7466484

SCHEMBL7466484

COC(=O)c1ccc2nc(N)c(-c3ccccc3)n2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 10/20 0.60
▸ AKT2 P31751 10/20 0.60
▸ ALDH1A1 P00352 2/20 0.50
▸ DAPK3 O43293 1/20 0.50
▸ JAK2 O60674 1/20 0.50
▸ PRKD3 O94806 1/20 0.50
▸ MAP4K4 O95819 1/20 0.50
▸ ABL1 P00519 1/20 0.50
▸ CSF1R P07333 1/20 0.50
▸ RET P07949 1/20 0.50
▸ MET P08581 1/20 0.50
▸ PDGFRA P16234 1/20 0.50
▸ PRKACA P17612 1/20 0.50
▸ LTK P29376 1/20 0.50
▸ GRK5 P34947 1/20 0.50
▸ KDR P35968 1/20 0.50
▸ MAPK8 P45983 1/20 0.50
▸ MAPK9 P45984 1/20 0.50
▸ CSNK1A1 P48729 1/20 0.50
▸ CDK8 P49336 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7678849 0.89 AKT1 (0.55) AKT1AKT2ALDH1A1DAPK3JAK2
SCHEMBL15050025 0.86 AKT1 (0.58) AKT1AKT2ALDH1A1ALDH1A3NPC1
SCHEMBL7467961 0.85 AKT1 (0.56) AKT1AKT2USP7CDK4CDK2
SCHEMBL7683226 0.83 AKT1 (0.48) AKT1AKT2USP7CDK4CDK2
SCHEMBL7683359 0.83 CDK2 (0.59) AKT1AKT2USP7CDK4CDK2
SCHEMBL7676382 0.80 USP7 (0.59) AKT1AKT2CDK5NPC1MAPT
SCHEMBL7676921 0.79 AKT1 (0.45) AKT1AKT2USP7CDK4CDK2
SCHEMBL7682754 0.79 CDK2 (0.58) AKT1AKT2CDK4CDK2
SCHEMBL7473818 0.79 SRD5A2 (0.43) AKT1AKT2MAPTUSP7CDK4
SCHEMBL7673469 0.79 CDK2 (0.57) AKT1AKT2USP7CDK4CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6410586-B1 ANTICOAGULANTS; INSULIN RESISTANCE; ANTIALLERGENS NOVO NORDISK A/S (DK) 2002-06-25 — — US disclosed
EP-1077701-A4 ANTI-VIRAL COMPOUNDS LILLY CO ELI (US) 2002-03-20 — — EP disclosed
US-6358971-B1 FOR INHIBITING THE GROWTH OF A PICORNAVIRUS ELI LILLY AND COMPANY 2002-03-19 — — US disclosed
EP-1077701-A1 ANTI-VIRAL COMPOUNDS ELI LILLY AND COMPANY (US) 2001-02-28 — — EP disclosed
WO-1999059587-A1 ANTI-VIRAL COMPOUNDS ELI LILLY AND COMPANY (US) 1999-11-25 — — WO disclosed
Send feedback